COMP <GO>
NICE vs QLYS // ENTERPRISE SCALE & MARKET CAP
NICE Ltd (NASDAQ) VS. Qualys Inc. (NASDAQ) • 15-METRIC TALLY: NICE 3
— QLYS 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: QLYS
LAST: $112.39 (-1.20%) • MKT CAP: $6.68B
market-cap
$6.68B
LAST: $207.60 (-7.37%) • MKT CAP: $7.18B
market-cap
$7.18B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NICE VS. QLYS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NICE | QLYS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.40% | 82.80% | -16.40 | QLYS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.30% | 27.50% | -16.20 | QLYS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.3x | 35.1x | -23.80 | NICE | /valuation <GO> |
| Free Cash Flow Yield | 10.21% | 3.82% | +6.39 | NICE | /fcf-yield <GO> |
| Operating Margin | 21.90% | 33.20% | -11.30 | QLYS | /operating-margins <GO> |
| Net Profit Margin | 20.80% | 29.60% | -8.80 | QLYS | /net-margins <GO> |
| Revenue Growth (YoY) | 7.70% | 10.10% | -2.40 | QLYS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.69 | 10.23 | -6.54 | QLYS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 50.2 | -4.40 | QLYS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.27 | 1.35 | -0.08 | QLYS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.4x | 37.4x | -27.00 | NICE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $6.68B | $7.18B | -$505.6M | QLYS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NICE REV | QLYS REV | NICE GROSS % | QLYS GROSS % | NICE FCF | QLYS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.95B | $669.1M | 66.4% | 82.8% | $697.6M | $304.4M |
| FY 2024 | $2.74B | $607.6M | 66.7% | 81.7% | $797.7M | $231.8M |
| FY 2023 | $2.38B | $554.5M | — | — | $454.4M | $219.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NICE // BETA 1.27
QLYS // BETA 1.35